Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation [NA]
This clinical trial evaluated CD8 donor lymphocyte infusion for relapse or residual disease after allogeneic stem cell transplantation. The …
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating the safety and efficacy of obatoclax mesylate in Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Psychosocial Impact of Cancer-Related Female Infertility
A completed clinical trial from MD Anderson Cancer Center studied the psychosocial impact of cancer-related female infertility among patient…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma [Phase 1]
This update summarizes a Phase 1 trial evaluating Velcade (bortezomib) in combination with ICE (ifosfamide, carboplatin, etoposide) for rela…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease [Phase 2]
Phase 2 clinical trial evaluating chemotherapy, radiation therapy, and autologous peripheral stem cell transplantation in patients with Hodg…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial investigating protection of ovarian function in female patients with Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: HD12 for Advanced Stages [Phase 3]
Clinical trial HD12, a Phase 3 study for advanced Hodgkin lymphoma, has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating peripheral stem cell transplantation after radiation therapy has completed in patients with Hodgkin lymp…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
This is a completed Phase 1/Phase 2 trial evaluating chemotherapy and radiation therapy with bone marrow or peripheral stem cell transplanta…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Hodgkin's Disease [Phase 2]
Phase 2 study of arsenic trioxide in relapsed or refractory Hodgkin lymphoma; the trial was terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of Lmp1 and Lmp2-specific cytotoxic T lymphocytes following CD45 antibody for relapsed EBV-positive Hodgkin lymphoma or non-Ho…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies [Phase 2]
Phase 2 trial of SB1518 in advanced lymphoid malignancies assessed safety and efficacy in Hodgkin lymphoma, mantle cell lymphoma, and indole…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies [Phase 1]
A Phase 1 study evaluating SB1518 in patients with advanced lymphoid malignancies (Hodgkin lymphoma and non-Hodgkin lymphoma) has been compl…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation [NA]
This clinical trial update reports on a study evaluating CD8+ T cell depletion as prophylaxis against graft-versus-host disease after periph…
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Blood Samples to Evaluate Biomarkers of Donor Chimerism
The document summarizes a completed trial examining blood-based biomarkers of donor chimerism. The study involves patients with hematologic …
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating sirolimus plus tacrolimus for graft-versus-host disease prophylaxis after related stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation [Phase 2]
A Phase 2 study evaluating sirolimus with tacrolimus for graft-versus-host disease prophylaxis after unrelated donor stem cell transplantati…
-
CLINICAL_TRIALS trial_result · 2012-01-25Clinical Trial Update: Brown Fat Activity and White Fat Accumulation
A completed clinical trial update from Children's Hospital Los Angeles studied brown fat activity and white fat accumulation in patients wit…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma [Phase 2]
Phase 2 clinical trial evaluating tipifarnib in relapsed or refractory lymphoma has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma [Phase 2]
This clinical trial update reports the results of a pivotal open-label Phase 2 study of Brentuximab Vedotin in Hodgkin lymphoma, sponsored b…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the safety and preliminary efficacy of SGN-30 (brentuximab vedotin) in patients with CD30-positive …
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients [Phase 1]
This Phase 1 study evaluated the safety and tolerability of an oral capsule form of PCI-24781 in adults with advanced cancers, and the trial…
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial update reports completion of a study evaluating radiation therapy with cyclophosphamide followed by peripheral stem cell …
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Trial of AVN-944 in Patients With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 trial evaluating AVN-944 in patients with advanced hematologic malignancies has completed, spanning acute and chronic leukemia, mu…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: HD11 for Intermediate Stages [Phase 3]
A Phase 3 clinical trial named HD11 for intermediate-stage Hodgkin lymphoma has completed, sponsored by the University of Cologne. The snipp…